-+ 0.00%
-+ 0.00%
-+ 0.00%

ATOSSA THERAPEUTICS RECEIVES FDA "STUDY MAY PROCEED" LETTER FOR (Z)-ENDOXIFEN INVESTIGATIONAL NEW DRUG APPLICATION FOR METASTATIC BREAST CANCER

Reuters·01/06/2026 13:15:00

Please log in to view news